SN

Sridevi Nandamuri

Active Director Additional Director DIN 09584174
DIN 09584174 First appointment Feb 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sridevi Nandamuri

Data last updated:

Sridevi Nandamuri is an Additional Director at Medure Life Sciences Private Limited (since 2023). The company operates in Chemicals.

DIN 09584174
Primary Designation Additional Director
Industry Chemicals
First Appointment 09 Feb 2023
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medure Life Sciences Private Limited U24239TG2021PTC157195
Additional Director09 Feb 20232021Active

Board colleagues of Sridevi Nandamuri

Directorship timeline

Open interactive timeline →
Medure Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sridevi Nandamuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridevi Nandamuri

Sridevi Nandamuri currently holds 1 directorship: Medure Life Sciences Private Limited (Additional Director, since 09 Feb 2023).

Sridevi Nandamuri was first appointed on 09 Feb 2023 as Additional Director at Medure Life Sciences Private Limited.

The current boards of Sridevi Nandamuri's companies include Moturi Krishna Prasad (Medure Life Sciences Private Limited), Srinivasa Rao Gude (Medure Life Sciences Private Limited), Swamy Pentyala (Medure Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available